Abbott is a healthcare company that develops products to improve quality of life at all stages. Abbott’s portfolio includes diagnostics, medical devices, nutritionals and branded generic medicines. They have over 110,000 employees globally with customers in over 160 countries worldwide. With 130 years of history, Abbott is an established presence in the healthcare industry.

Abbott’s portfolio has products targeted towards several categories, including cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines. 

Some of Abbott’s best known brands include: Similac, a line of infant formulas; EleCare, a nutritionally complete, amino acid-based medical good and infant formula with iron; PediaSure, balanced nutrition for kids on the go; Pedialyte, a formulation to prevent dehydration by restoring lost minerals and nutrients; Ensure, a line of nutrition products supporting active lifestyles; FreeStyle, a glucose monitor to make managing diabetes easier and more convenient; FreeStyle Libre, a handheld reader with a small sensor that continuously monitors glucose levels, eliminating routine finger sticks; and Glucerna, specialized nutrition to help maintain health blood glucose levels and manage diabetes.

Biotechnology

Health Care

Health Diagnostics

Medical Devices

Pharmaceutical

Abbott

Dr. Alpern has served as the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine since June 2004. From July 1998 to June 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. Dr. Alpern also serves as a Director of AbbVie Inc. and Tricida, Inc. and as a Director on the Board of Yale New Haven Hospital.

As the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine, Dean of The University of Texas Southwestern Medical Center, and as a Director on the Board of Yale New Haven Hospital, Dr. Alpern contributes valuable insights to the Board through his medical and scientific expertise and his knowledge of the health care environment and the scientific nature of Abbott's key research and development initiatives.

Robert J. Alpern

Ms. Blount is the Michael L. Nemmers Professor of Strategy and was the Dean of the J.L. Kellogg Graduate School of Management at [Northwestern University](/org/northwestern-university) from July 2010 to August 2018. From 2004 to 2010, she served as the Vice Dean and Dean of the Undergraduate College of New York University's Leonard N. Stern School of Business. Ms. Blount joined the faculty of New York University's Leonard N. Stern School of Business in 2001 and was the Abraham L. Gitlow Professor of Management and Organizations. Prior to joining NYU in 2001, Ms. Blount held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001. Ms. Blount currently serves on the Board of Directors of Ulta Beauty, Inc. and the Joyce Foundation.

As former Dean of the J.L. Kellogg Graduate School of Management at [Northwestern University](/org/northwestern-university) and as the former Vice Dean and Dean of the Undergraduate College of New York University's Leonard N. Stern School of Business, Ms. Blount provides Abbott’s Board with expertise on business organization, governance and business management matters.

Sally E. Blount

Mr. Roman has served as the Chairman of the Board, President and Chief Executive Officer of 3M Company since May 2019. Previously, he served as Chief Executive Officer from July 2018 to May 2019 and as Chief Operating Officer and Executive Vice President from July 2017 to June 2018 with direct responsibilities for 3M's five business groups and its international operations. From June 2014 to July 2017, Mr. Roman served as 3M's Executive Vice President, Industrial Business Group. He served as 3M's Senior Vice President, Business Development, from May 2013 to June 2014 and as Vice President and General Manager of Industrial Adhesives and Tapes Division from September 2011 to May 2013.

As Chairman of the Board, President and Chief Executive Officer of 3M Company, Mr. Roman has extensive experience leading a multinational public company with multiple businesses, contributing significant manufacturing, supply chain, technology, and finance experience, as well as valuable insights into corporate strategy and risk management.

Michael F. Roman

Nancy McKinstry is the current Director at Abbott. Nancy has an extensive background in product management and marketing, which they have used to great effect in their current role. Prior to joining Abbott, Nancy held various positions at [Russell Reynolds Associates](/org/russell-reynolds-associates), where they were responsible for product development and marketing of electronic products. Nancy also served as Vice President of Product Management and Senior Officer at [Wolters Kluwer](/org/wolters-kluwer), where they introduced over 100 new products and increased electronic product revenues from $12M to $53M. Nancy has also held positions at Columbia Business School and [Booz Allen Hamilton](/org/booz-allen-hamilton).

Nancy McKinstry earned their MBA in finance and marketing from Columbia Business School and their B.A. in economics and political science from the [University of Rhode Island](/org/university-of-rhode-island).

Nancy McKinstry

Sarah McDermott is a CAPA Specialist at Abbott. Sarah previously worked as a Document Controller at BECK Interiors from September 2016 to December 2017. During their time at BECK, Sarah worked on multiple projects based both onsite in London and at Head Office. Projects varied from residential to luxury hotels, in addition to working on a museum opening in Kuwait. As a Document Controller, Sarah was responsible for uploading BECK, client and subcontractor drawings, distributing for approval, information and construction using Asite. Sarah also updated the Technical Submission Schedule, RFI register and drawing register. In addition to their work as a Document Controller, Sarah also served as Secretary to the block project manager for the SAASCC Museum in Kuwait. In this role, they managed all document administration for two major blocks of the Museum, providing comprehensive secretarial document control. Sarah also has experience working on residential projects in London, where they were responsible for document control, general admin, O&M’s & collateral warranties.

Sarah McDermott attended Blenheim High School.

Their manager is Cormac Rudden, CAPA / Validation Manager. Sarah McDermott works with Hannah Byrne - Quality Excellence and PoP Site Lead, Martin Farrelly - QA Validation Engineer, and Claire Lynch - Lead QA Validation Engineer.

Sarah McDermott

Hannah Byrne is currently the Quality Excellence and PoP Site Lead at Abbott. Prior to this, they worked as a QC/ Analytical Laboratory Assistant at Megazyme and completed a Research Project entitled "TSHZ3 Control of Myogenic Differentiation of Resident Vascular Stem Cells" as part of their degree programme at [Dublin City University](/org/dublin-city-university).

Byrne has always been interested in the sciences and was drawn to the field of cardiovascular research after witnessing the effects of cardiovascular disease first-hand in their own family. During their time at DCU, they were able to gain invaluable experience in cell culture, RNA isolation, qRT-PCR and targeted knock-downs.

Byrne is passionate about their work and is constantly striving to improve their knowledge and skills in order to make a positive impact in the field of cardiovascular research.

Hannah Byrne works with Sarah McDermott - CAPA Specialist, Martin Farrelly - QA Validation Engineer, and Claire Lynch - Lead QA Validation Engineer. Hannah Byrne reports to Cormac Rudden, CAPA / Validation Manager.

Hannah Byrne

Mylene Moraes is currently the Executive Assistant to the EVP of Rapid and Molecular Diagnostics at Abbott. Prior to this, they worked as Sr. Executive Assistant to the EVP of Medical Affairs at [Astellas Pharma](/org/astellas-pharma) from March 2016 to April 2018. In this role, they were responsible for schedule management, travel arrangements, coordinating flights and accommodations, and overseeing junior level staff. Mylene also was responsible for drafting correspondence, speeches, presentations, press materials, and announcements from the executive office. Mylene has a long history of experience in facilitating communication, event planning, distributing information, and drafting agendas and schedules for meetings.

Mylene Moraes has a degree in Human Resources Management/Personnel Administration, General from [Villanova University](/org/villanova-university). Mylene also has a degree in Physical Education (Santos, Sao Paulo, Brazil) from Faculdade de Educacao Fisica de Santos.

They are on a team with Damian Halloran - VP, Infectious Disease Emerging Markets, Abbott Rapid Diagnostics, Mark Szewczyk - GM, Molecular Diagnostics Division, and Stuart Knight - VP, Global Accounts, Infectious Disease Rapid Diagnostics. Mylene Moraes reports to Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics.

Mylene Moraes

Conor Cronin is the VP of Marketing & Commercial Ops EMEA for Cardiometabolic at Abbott. Conor has over 25 years of experience in the healthcare industry, with a focus on diagnostics and oncology. Conor has held previous positions as the Vice President of Marketing and Medical Affairs for Alere Inc. and as the Director of Global Sales & Marketing for Delcath Systems, Inc. Conor has a proven track record in successfully launching new products and driving growth in both small and large organizations. Conor is a strategic thinker with a passion for bringing innovative products to market that improve patient outcomes.

Conor Cronin has a Bachelor of Business Studies (BBS) from the University of Limerick in Marketing and Law. Conor also has a Master of Business Administration (MBA) from the University of Limerick. Conor has completed executive programs at Columbia Business School in Leading Strategic Growth and [Harvard Business School](/org/harvard-business-school) in Corporate Finance. Conor also has a certification from Columbia Business School in Leading Strategic Growth.

They work with Paul Bould - VP, Global Marketing Insights & Analytics, Simon Goldberg - Senior Director, Global Digital Marketing, and Chris Miller - Divisional VP, Global Brand Strategy & Innovation. Conor Cronin reports to Melissa Brotz, Chief Marketing and Communications Officer.

Conor Cronin

Christopher Slachta is currently the Divisional VP of Operations for Molecular Diagnostics at Abbott. Prior to this, they served as the General Manager of Operations and Senior Director of Transfusion Medicine Operations at [Ortho Clinical Diagnostics](/org/ortho-clinical-diagnostics) from January 2002 to December 2012. Before that, they were a Comissioned Officer in the US Army from July 1989 to July 2001, where they attained the rank of Captain in the Infantry.

Christopher Slachta has a PhD in Molecular Immunology and Microbiology from Temple University - Lewis Katz School of Medicine, an MBA in Executive from Rutgers University - Newark, and a Post-Doc in Virology and Immune Tolerance from University of Pennsylvania School of Medicine. Christopher also has a Bachelor of Science in Clinical Laboratory Sciences from Temple University College of Allied Health. In addition, they have certification from [Ortho Clinical Diagnostics](/org/ortho-clinical-diagnostics) in Process Excellence 6-Sigma Green Belt and from American Society for Clinical Pathology (ASCP) in MT(ASCP) and MT(ASCP)BB.

Christopher Slachta works with Stephanie McCallum - Ethics and Compliance Officer, Rapid and Molecular Diagnostics, Ramon Neira - Division VP and Controller, Emerging Markets, Infectious Diseases, Rapid Diagnostics, and Mark Szewczyk - GM, Molecular Diagnostics Division. Christopher Slachta reports to Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics.

Christopher Slachta

Joe Morrow has been with Abbott since July 1988, when they started as a cost accountant. Joe quickly rose through the ranks and is now the divisional vice president of global supply chain. Prior to joining Abbott, Joe worked for [American Greetings](/org/american-greetings-corporation-llc) from June 1986 to July 1988 as a cost accountant. Before that, they were with [Motorola Solutions](/org/motorola-solutions) from May 1984 to June 1986 as an accountant. Joe is a highly skilled and talented individual with a long history of success in the accounting and finance industry.

Joe Morrow has a Bachelor of Business Administration from [Texas Christian University](/org/texas-christian-university) in Accounting and Finance.

They work with Robert Funck - EVP, Finance & CFO, John F. Ginascol - EVP, [Core Diagnostics](/org/corediagnostics), and John M. Capek - EVP, Ventures. Joe Morrow reports to Robert B. Ford, President & CEO.

Joe Morrow

Harvinder Singh is currently the VP, Global Commercial for Abbott Vascular. Prior to this role, they served as the Divisional Vice President for Asia Pacific & Japan for Abbott from September 2013 to August 2019. From November 2008 to September 2013, they were the Divisional Vice President & General Manager for Japan. In this role, they were responsible for Abbott Vascular's business in Japan with a key focus on delivering the Japan P&L. Singh also served as the General Manager & Regional Director North Asia for Abbott from July 2006 to October 2008. In this role, they were responsible for the strategic business planning for Guidant Corporation in the APAC region. Prior to joining Abbott, Singh served as the Marketing Manager - Vascular Intervention for Abbott Vascular APAC from July 2002 to May 2005.

Harvinder Singh's educational career began with an advanced management program in marketing from [Harvard Business School](/org/harvard-business-school). Harvinder then went on to earn their MBA in marketing from the Institute of Management Studies Indore. Finally, they completed a program for leadership development in general management from [Harvard Business School](/org/harvard-business-school).

Some of their coworkers include Krishna Sudhir - VP, Medical Affairs and Product Performance, Abbott Vascular, Erik Ahlberg - GM, Abbott Vascular, Southeast Asia, and Nick West - Chief Medical Officer & DVP, Global Medical Affairs, Abbott Vascular. Their manager is Julie Tyler, SVP, Vascular.

Harvinder Singh

Ferruh Cem Arkilic is the Chief Medical Officer of Innovation and Development at Established Pharmaceuticals at Abbott. Dr. Arkilic has over 25 years of experience in the medical field, including clinical research, healthy volunteer studies, phase II-IV clinical studies, and emergency care physician. Ferruh has worked in various prestigious institutions such as the Washington University School of Medicine, the [Medical University of Vienna](/org/medical-university-of-vienna), and the Turkish Naval Forces. Dr. Arkilic is a well-renowned doctor and has won numerous awards for their work in the medical field.

Ferruh Cem Arkilic is a medical doctor who has studied medicine at Anadolu University. Ferruh also has a college education from Balikesir High School.

Ferruh Cem Arkilic reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products. Ferruh Cem Arkilic works with Ivan Martinez - Division VP, Strategic Initiatives, Abbott Nutrition, Ebru Kaya - General Manager, Abbott Nutrition, Turkey, and Sammy G. Karam - SVP, Emerging Markets Established Pharmaceuticals.

Ferruh Cem Arkilic

Michael Crowe is currently the Vice President of Manufacturing Operations at Abbott Vascular. Michael has over 20 years of experience in global operations, product development, and program management. 

Crowe began their career at [Johnson & Johnson](/org/johnson-johnson) in August 2000 as the General Manager of [Ortho Clinical Diagnostics](/org/ortho-clinical-diagnostics). In December 2002, they were promoted to Managing Director/Vice President of Global Operations for LifeScan, a division of [Johnson & Johnson](/org/johnson-johnson). Michael held this position for five years before moving to Covidien Surgical Devices in December 2008 as the Vice President of Global Operations. 

At Covidien, Crowe was responsible for leading the full supply chain for a $3 billion surgical product company with seven global facilities and 6,000 employees. Michael oversaw the Program Management Office and led new product development activity in a dynamic product leadership environment. In three years, they launched 30 new products that accounted for $500 million in annual revenues. Michael delivered 4-5% productivity each year and launched an asset reconfiguration project that significantly improved operating margins. Overall, their financial results added more than 3 points of margin in two years to the division's results.

In August 2007, Crowe moved to [Johnson & Johnson](/org/johnson-johnson)'s Consumer Group as the Vice President of Operations Improvement. Michael held this position for one year before returning to Covidien in December 2008 as the Vice President of Global Operations.

Crowe has been with Abbott Vascular since September 2011 and currently serves as the Vice President of Manufacturing Operations.

Michael Crowe has an MBA from [Duke University](/org/duke-university) and a BS in Electrical Engineering from the [University of Louisville](/org/university-of-louisville). Michael is currently a field sales manager at [Northwestern University](/org/northwestern-university).

Michael Crowe reports to Julie Tyler, SVP, Vascular. Michael Crowe works with Harvinder Singh - VP, Global Commercial, Abbott Vascular, Krishna Sudhir - VP, Medical Affairs and Product Performance, Abbott Vascular, and Nick West - Chief Medical Officer & DVP, Global Medical Affairs, Abbott Vascular.

Michael Crowe

Krishna Sudhir, VP of Medical Affairs and Product Performance at Abbott Vascular, has a long and accomplished history in the medical field. Krishna began their career as a consultant cardiologist at Alfred Heart Center and Alfred Hospital before moving on to become Co-Director of the Hormones and the Vasculature Lab at Baker IDI Heart and Diabetes Institute. From there, they became Director of the Vascular Research Laboratory at UCSF.

In 2001, Sudhir began working in the pharmaceutical industry, first as Director of Cardiovascular Research at [Pharmacyclics](/org/pharmacyclics), then as Director of Clinical Development at Millennium Pharmaceuticals. In 2003, they took on the role of Vice President of Medical Affairs at diaDexus. In 2004, they left diaDexus to become Executive Director of Macroflux Internal Venture at [Johnson & Johnson](/org/johnson-johnson), where they stayed until 2006.

Sudhir has been with Abbott since 2006, first as Director of Global Regulatory Affairs for Abbott Vascular Devices, then as Vice President of Regulatory Affairs for Abbott Vascular. In their current role as VP of Medical Affairs and Product Performance, they are responsible for leading the global clinical affairs organization and overseeing the performance of all Abbott Vascular products.

Krishna Sudhir has a diploma in global business from [Harvard Business School](/org/harvard-business-school). Krishna is also a fellow of the Society of Cardiac Angiography and Interventions and the American College of Cardiology. In addition, they have a certificate course in artificial intelligence from DeepLearning.AI. Krishna also has a cardiovascular fellowship from the University of California, San Francisco. Lastly, they have a doctor of philosophy (PhD) from the Baker Medical Research Institute and [Monash University](/org/monash-university).

Krishna Sudhir reports to Julie Tyler, SVP, Vascular. Krishna Sudhir works with Erik Ahlberg - GM, Abbott Vascular, Southeast Asia, Michael Crowe - VP, Manufacturing Operations, Abbott Vascular, and Harvinder Singh - VP, Global Commercial, Abbott Vascular.

Krishna Sudhir

Damian Halloran is the current VP of Infectious Disease Emerging Markets at Abbott Rapid Diagnostics. Prior to this role, they served as the Divisional Vice President of Global Manufacturing Operations for Abbott Nutrition and the Division Vice President of Global Operations for Abbott Vascular. 

During their time at Abbott Nutrition, Damian was responsible for supporting over $7 billion of sales via 14 manufacturing locations spread globally, as well as 30+ TPMs. Damian oversaw a large engineering function and was responsible for significant capital budgets and greenfield start-ups globally. Three new greenfields were built during their tenure - in the USA, China, and another in the USA. Damian also played a key role in evolving the Global Operational Excellence culture across Abbott Nutrition's supply chain, delivering over $200 million in improvements within three years. 

At Abbott Vascular, Damian was responsible for Global manufacturing, engineering, and supply chain operations for the entire division. This included oversight of 5 global sites and two distribution centers, supporting over $3 billion in sales with 4,000 employees. During their tenure they led the site selection and start-up of Costa Rica manufacturing location. Damian also launched a very effective Division-wide Operational Excellence program that delivered over $150 million in margin improvements. In addition, Damian played key roles in launching and ramping up the Xience DES product and was also a key member of the Guidant acquisition team.

Damian Halloran has a Bachelor of Manufacturing Technology in Engineering from [National University of Ireland, Galway](/org/national-university-of-ireland-galway). Damian also has a CPIM (Certified in Production and Inventory Management) from APICS Chapter in Ireland. Damian is certified by the American Production and Inventory Control Society in APICS.

Their manager is Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics. They are on a team with Stuart Knight - VP, Global Accounts, Infectious Disease Rapid Diagnostics, Mahesh Natarajan - GM, Molecular Diagnostics, Asia Pacific, and Adam Bishop - US VP of Sales, Infectious Disease Rapid Diagnostics.

Damian Halloran

Hakim Bouzamondo is the current Divisional Vice President, Head of Global Nutrition Research & Development at Abbott. Hakim has over 20 years of experience in the pharmaceutical and healthcare industry. 

Bouzamondo started their career at Merck KGaA in 1999 as a Global Medical Lead, Research & Development. In 2006, they moved to Bristol-Myers Squibb as an EMEA Medical Lead, Metabolics. Hakim then became the Global Clinical Head Foods & Refreshment, and Head of Clinical in Asia at [Unilever](/org/unilever) from 2011 to 2014. In their current role at Abbott, Bouzamondo is responsible for leading the global nutrition research and development team.

Hakim Bouzamondo attended Pierre and Marie Curie University, where they earned a Master of Science in Pharmacology. Hakim then pursued post-doctoral degrees in clinical pharmacology/Pks/ Psychoactive drugs at the same school. In 1993, they earned a Medical Doctor from Algiers University. Hakim later earned an Executive MBA from Ashridge Executive Education at [Hult International Business School](/org/hult-international-business-school).

Hakim Bouzamondo works with Jawed Zia - VP, Established Pharmaceuticals, India, Jim Jin - GM, Established Pharmaceuticals, China, and Marc Lam - Divisional VP & Controller, Established Pharmaceuticals. Hakim Bouzamondo reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products.

Hakim Bouzamondo

Ramon Neira is currently the Division VP and Controller, Emerging Markets, Infectious Diseases, Rapid Diagnostics at Abbott. Prior to this, they were the Regional Finance Director at [Sony Music Entertainment](/org/sony-music-entertainment) from September 2000 to March 2001. Before that, they were the Finance Manager at [Pfizer](/org/pfizer) from November 1995 to September 2000. Ramon has also worked as a Financial Analyst at [Air Products](/org/air-products-chemicals) from January 1993 to December 1995. Prior to that, they were the Financiar Analysis Mgr. at The Goodyear Tire & Rubber Company from January 1987 to December 1991.

Ramon Neira holds a Bachelor of Science in Industrial Engineering from Pontificia Universidad Javeriana, a Master of Business Administration from [Virginia Tech](/org/virginia-tech), and a Master of Business Administration from Virginia Polytechnic Institute and State University. Ramon is currently pursuing a Graduate Studies in Finance at Pontificia Universidad Javeriana.

Ramon Neira reports to Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics. Ramon Neira works with Mahesh Natarajan - GM, Molecular Diagnostics, Asia Pacific, Edita Apuokiene - VP, Molecular Diagnostics, EMEA, and Mylene Moraes - Executive Assistant to EVP, Rapid and Molecular Diagnostics.

Ramon Neira

Melissa Brotz is the Chief Marketing and Communications Officer at Abbott. Melissa has over 20 years of experience in public relations, with a focus on the health care industry. Melissa has a proven track record of successful business development and media relations. Melissa is a strategic thinker who is able to create and execute public relations programs that achieve results.

Melissa Brotz graduated with a Bachelor of Science in Journalism from [Northwestern University](/org/northwestern-university). Melissa also double majored in Political Science while at Northwestern.

Some direct reports include Simon Goldberg - Senior Director, Global Digital Marketing, Conor Cronin - VP, Marketing & Commercial Ops EMEA, Cardiometabolic, and Chris Miller - Divisional VP, Global Brand Strategy & Innovation. Melissa Brotz reports to Robert B. Ford, President & CEO. Melissa Brotz works with John F. Ginascol - EVP, [Core Diagnostics](/org/corediagnostics), Mary K. Moreland - EVP, Human Resources, and Hubert L. Allen - EVP, General Counsel & Secretary.

Melissa Brotz

Simon Goldberg is the Senior Director of Global Digital Marketing at Abbott. Simon has over 25 years of experience in the field of communications and policy, and has been a part of some of the most important scientific discoveries of our time. Simon played a pivotal role in the mapping of the human genome, and was one of the first to develop a new technique to capture short-strand DNA. Simon has also worked extensively in the area of life science and biotech investment strategy, and has helped increase the valuation of many companies by more than 10%. In their current role at Abbott, Simon is responsible for leading the digital marketing efforts for all of Abbott’s products and services.

Simon Goldberg earned a MBA from DePaul Driehaus College of Business with a focus in entrepreneurship and marketing. Prior to that, they completed a BS in cellular molecular biology from the University of Michigan. Simon also holds an MS in human genetics and genetic counseling from the [University of Pittsburgh](/org/university-of-pittsburgh).

Their manager is Melissa Brotz, Chief Marketing and Communications Officer. Some of their coworkers include Paul Bould - VP, Global Marketing Insights & Analytics, Chris Miller - Divisional VP, Global Brand Strategy & Innovation, and Conor Cronin - VP, Marketing & Commercial Ops EMEA, Cardiometabolic.

Simon Goldberg

George Zamanakos is currently the Divisional VP of Global Strategic Marketing for Abbott Diabetes Care. Prior to this, they were with DreamSaga LLC and [Bigfoot Biomedical](/org/bigfoot-biomedical) as a Board Observer, responsible for global brand management, innovation strategy, market research, business development, and market access functions. George also spent time with Abbott as the Divisional Vice President of Global Strategic Marketing for Diabetes Care, where they were responsible for a $4 billion diabetes business globally. This included marketing and brand management, business development, innovation strategy, market access, and project management with focus on the groundbreaking FreeStyle Libre technology. George is experienced in digital solutions strategy and implementation, and has a broad network of business and technology partnerships. George is a member of the senior management team and has led a global team of 120 FTEs.

George Zamanakos completed their PhD in Physics at Caltech, with a minor in Computer Science. George received their BS in Physics from Ethnikon kai Kapodistriakon Panepistimion Athinon.

Some of their coworkers include Michael Johnson - Divisional VP Human Resources, Abbott Diabetes Care, Scott Harper - Division VP, Research and Development, Abbott Diabetes Care, and Adam Cate - General Manager, US Consumer Sales and Marketing, Diabetes Care. George Zamanakos reports to Jared L. Watkin, SVP, Diabetes Care.

George Zamanakos

Marc Taub is the Divisional VP of Technical Operations for Abbott Diabetes Care. Prior to this role, they served as Senior Director of R&D from September 2015 to June 2018, Director of R&D from July 2014 to September 2015, Technical Director of R&D from June 2011 to July 2014, and Manager of Research and Development from April 2010 to June 2011. Marc also spent time as Manager of Regulatory Affairs from June 2009 to March 2010. Before joining Abbott in 2006, Marc was a Senior Scientist for Technology Assessment at another company. Marc began their career as a Senior Engineer for R&D at Abbott in 2003.

Marc Taub has a doctorate from [Stanford University](/org/stanford), a master's from [Stanford University](/org/stanford), and a bachelor's from [Brown University](/org/brown-university). Marc also attended Hunter College High School.

They are on a team with George Zamanakos - Divisional VP, Global Strategic Marketing, Abbott Diabetes Care, Duncan Williams - Divisonal VP, New Analyte Ventures, Abbott Diabetes Care, and Michael Johnson - Divisional VP Human Resources, Abbott Diabetes Care. Marc Taub reports to Jared L. Watkin, SVP, Diabetes Care.

Marc Taub

Ivan Martinez is the Division Vice President of Strategic Initiatives for Abbott Nutrition. In this role, they are responsible for global functions such as gross margin improvement, digital innovation & governance, cross border e-commerce, strategy & business development, and several other global strategic programs. Ivan is also a core member of the Abbott Nutrition senior leadership staff, reporting to the Executive Vice President/President of Abbott Nutrition.

Prior to their current role, Martinez served as the Chief Strategy Officer, Chief Products Officer, and General Manager of the Digital Business Services division for [Brillio](/org/brillio). In this role, they were responsible for leading the company's efforts in identifying new technology strategies to help businesses transform and advance their performance and competitiveness. Ivan was also responsible for [Brillio](/org/brillio)'s global expansion efforts, overseeing the company's operations in Americas, Europe, and Asia.

Martinez has over 25 years of experience in the technology industry. Ivan holds a Bachelor's degree in Electrical Engineering from the University of Texas at Austin and a Master's degree in Business Administration from the University of Chicago Booth School of Business.

Ivan Martinez has a MBA from Northwestern University - Kellogg School of Management, a Master en Direccion y Administracion de Empresas from CESMA Business School, an MSEE from Universidad Politécnica de Madrid, and a degree in Music from Luigi Boccherini/ Carlos Soto School of Music.

Some of their coworkers include Sammy G. Karam - SVP, Emerging Markets Established Pharmaceuticals, Ferruh Cem Arkilic - Chief Medical Officer, Innovation and Development, Established Pharmaceuticals, and Jawed Zia - VP, Established Pharmaceuticals, India. Ivan Martinez reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products.

Ivan Martinez

Hugues Gervais is a Divisional VP at Abbott. Hugues has over 20 years of experience in the industry, including positions at UFI Entrepreneurs, [Medtronic](/org/medtronic), [Johnson & Johnson](/org/johnson-johnson), and [Procter & Gamble](/org/procter-gamble).

Gervais has always been interested in high value added industries such as medical devices and healthcare. In September 2012, they founded UFI Entrepreneurs with the objective of acquiring, managing, and developing a company operating in such an industry. To date, they have successfully evaluated and made offers on three companies with turnovers of 45 million, 25 million, and 10 million dollars.

Prior to their work at UFI Entrepreneurs, Gervais served as business director for cardiac rhythm management at [Medtronic](/org/medtronic). Before that, they were European marketing manager at [Johnson & Johnson](/org/johnson-johnson). Gervais began their career as a project manager at [Procter & Gamble](/org/procter-gamble).

Throughout their career, Gervais has demonstrated an ability to source and evaluate target companies, raise funds from private equity investors and family offices, and negotiate acquisitions. Their experience in high value industries makes him a valuable asset to Abbott.

Hugues Gervais studied at three different schools for their educational career. Hugues started with a Master of Science in Engineering from [Stanford University](/org/stanford). Hugues then got their MBA in General Management from [INSEAD](/org/insead). Lastly, they got their Msc in Mechanical Engineering from Arts et Métiers ParisTech - École Nationale Supérieure d'Arts et Métiers. Hugues also has a Certificate in Artificial Intelligence in Healthcare from [Stanford University](/org/stanford).

They are on a team with Santosh Prabhu - Divisional VP, Product Development, Structural Heart, Dan Silver - GM, Structural Heart, Japan, and Payal Agrawal - GM and Country Head, Structural Heart, India & subcontinent. Hugues Gervais reports to Michael Dale, SVP, Structural Heart.

Hugues Gervais

Dan Silver is the current General Manager of Structural Heart, Japan at Abbott. Prior to this role, they served as Country Principal of Consulting & Services for Taiwan & Hong Kong at IMS Health from 2009 to 2011. From 2004 to 2009, Silver was the Director of Marketing at C.R. Bard, Inc., Japan Division. Eurasia Group was their employer from 2002 to 2004 where they worked as a Senior Asia Consultant. From 1998 to 2002, they worked as Director of International Sales at Endocare, Inc. Dan's first professional position was as Senior Associate and Healthcare Practice Head at Technomic Consultants China from 1993 to 1997.

Dan Silver's educational career includes a B.A. from [Brandeis University](/org/brandeis-university) in Dan'story/Chinese Studies, an M.A. from [Harvard University](/org/harvard) in Regional Studies - East Asia, and a Master of Arts - MA from [Harvard University](/org/harvard).

Their manager is Michael Dale, SVP, Structural Heart. They work with Sven Seyffert - Area Head and GM, Structural Heart, APAC, Payal Agrawal - GM and Country Head, Structural Heart, India & subcontinent, and Hugues Gervais - Divisional VP, Structural Heart, EMEA.

Dan Silver

Payal Agrawal is the current General Manager and Country Head of Structural Heart for Abbott in India and the subcontinent. Payal has previously worked as the General Manager for India at [Johnson & Johnson](/org/johnson-johnson) from January 2015 to September 2019. There, they were also a member of the Management Committee and the Executive member of AMCHAM's Diversity & Inclusion Council. Prior to that, they worked as a Head for CAT A+ (Mega Branches) & Branch Banking Strategy at [IndusInd Bank](/org/indusind-bank-ltd) from January 2012 to December 2015. Payal started their career as a Consultant at The Boston Consulting Group from April 2008 to April 2012, where they were also a Summer intern from January 2007 to December 2007.

Payal Agrawal holds a Master of Business Administration from the Indian Institute of Management Bangalore, as well as a B.E from B. M. S. College of Engineering. Payal specialize in strategy and marketing.

They are on a team with Ryan Derrigan - GM, Structural Heart, Northern Europe, Hugues Gervais - Divisional VP, Structural Heart, EMEA, and Dan Silver - GM, Structural Heart, Japan. Their manager is Michael Dale, SVP, Structural Heart.

Payal Agrawal

Sven Seyffert is the current Area Head and GM of Structural Heart for APAC at Abbott. Prior to joining Abbott, they worked for [Medtronic](/org/medtronic) for over 9 years in progressively senior roles in marketing and business development for their endovascular therapies and structural heart disease businesses in Asia Pacific. Sven started their career in the healthcare industry as a programmer and project manager at [Cardinal Health](/org/cardinal-health).

Sven Seyffert has an MBA from The Wharton School and a Bachelor's of Science in Management Information Systems from [The Ohio State University](/org/the-ohio-state-university).

They work with Payal Agrawal - GM and Country Head, Structural Heart, India & subcontinent, Santosh Prabhu - Divisional VP, Product Development, Structural Heart, and Mike Quinn - Area VP of Sales, Structural Heart. Sven Seyffert reports to Michael Dale, SVP, Structural Heart.

Sven Seyffert

Leo Goldshteyn is the current Divisional VP, Established Pharmaceuticals, Asia Pacific at Abbott. Prior to this, they were a Board Member at Veropharm from December 2014 to December 2015. Goldshteyn has also worked for Abbott in the past.

Leo Goldshteyn has an MBA in Marketing from [Marquette University](/org/marquette-university), a Bachelor of Science in Finance from [DePaul University](/org/depaul-university), and a certification from Columbia Business School in Leading Strategic Growth: Executive Education Program with Columbia Business School and Execonline, Inc.

They work with John Murphy - VP, Supply Chain, Nutrition, Jawed Zia - VP, Established Pharmaceuticals, India, and Ferruh Cem Arkilic - Chief Medical Officer, Innovation and Development, Established Pharmaceuticals. Leo Goldshteyn reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products.

Leo Goldshteyn

Jim Jin is the current General Manager for Established Pharmaceuticals in China at Abbott. Jim has held various positions at different companies throughout their career. 

Jim started at MSD in 1996 as a sales representative and eventually became a Regional Promotion Manager. In 2002, they transitioned to a Regional Sales Manager and then to a Business Development Manager in 2004. In 2007, they completed the MSD Marketing Development Program before becoming a Marketing Manager in 2008. 

Jim left MSD in 2010 to become the Marketing Director for Franchise Integration but returned later that year as the Associate Marketing Director for the ID Franchise. Jim eventually became the Head of Metabolism Business Unit for Biopharma in China before leaving in 2017 to join [Merck Group](/org/merck-group) as the Head of General Medicine and Endocrinology Business Unit for Biopharma in China. Jim held this position until 2019 when they joined Abbott as their GM for Established Pharmaceuticals in China.

Jim Jin's educational career includes a bachelor's degree from Shanghai Normal University and a master's degree.

Jim Jin reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products. They are on a team with Leo Goldshteyn - Divisional VP, Established Pharmaceuticals, Asia Pacific, Ferruh Cem Arkilic - Chief Medical Officer, Innovation and Development, Established Pharmaceuticals, and Joseph Manning - SVP, International Nutrition.

Jim Jin

Jawed Zia has been with Abbott for over two years, serving as Vice President of Established Pharmaceuticals for India. In this role, they are responsible for the company's operations in India, including manufacturing, research and development, logistics, sales and marketing.

Prior to joining Abbott, Jawed worked for [Rivaara Labs](/org/rivaara-labs) as a Senior Manager. Jawed has also held positions at other pharmaceutical companies, such as [Pfizer](/org/pfizer) and [Novartis](/org/novartis).

Jawed has a deep understanding of the Indian healthcare market and has been instrumental in Abbott's success in the country. Under their leadership, the company has seen significant growth and expansion in India.

Jawed is a graduate of the University of Mumbai, where they earned their degree in Pharmacy. Jawed is also a registered pharmacist in India.

Jawed Zia has a Master of Business Administration (MBA) from [Trinity College Dublin](/org/trinity-college-dublin) in Marketing and International Business. Jawed also has a Bachelor of Science (B.Sc.) from the All India Institute of Medical Sciences in Human Biology (Pharmacology).

Some of their coworkers include Alejandro Wellisch - SVP, Established Pharmaceuticals, Latin America, Sammy G. Karam - SVP, Emerging Markets Established Pharmaceuticals, and Leo Goldshteyn - Divisional VP, Established Pharmaceuticals, Asia Pacific. Jawed Zia reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products.

Jawed Zia

Allen Pofahl is the current Division VP of IT for Abbott Medical Devices. Prior to this role, they served as Head of IT for Abbott's Vascular Division as part of the Medical Device Division. In this role, they were responsible for ensuring IT was aligned to the business and delivering the required programs and projects for the business. Before this, Pofahl served as Vice President of IT for Operations and Quality Applications for both St. Jude Medical and Abbott. In this role, they were responsible for business relationship management, project delivery, and applications supporting the operations and quality organizations. Pofahl began their career at St. Jude Medical as the Director/Senior Director of Information Technology for the Cardiovascular Division.

Allen Pofahl has a Bachelor's Degree in Accounting from [Luther College](/org/luther-college). Allen is also certified as a Certified Information Systems Auditor (CISA) and a Certified Public Accountant (CPA).

Their manager is Lisa D. Earnhardt, EVP, Medical Devices. They are on a team with Elizabeth Cushman - Division VP and Associate General Counsel, Medical Devices, Chris Tyberg - Division VP, Information Security Abbott Medical Devices, and Brandy Corneil - Sr. Director, International Quality, Medical Devices.

Allen Pofahl

Tara Zerby is currently the Vice President of Global Cardiac Rhythm Management at Abbott. Tara has held this position since December of 2019. Prior to their current role, Tara served as the Vice President of Global Business Development, Strategy, & Marketing for Pain Stim and Early Intervention at [Medtronic](/org/medtronic) from September 2014 to December 2019. Before [Medtronic](/org/medtronic), Tara was with [Boston Scientific](/org/boston-scientific) as the Vice President of Marketing for EP from January 2011 to May 2014. Tara's career began at Cardiva Medical where they served as the Vice President of Business Development and Marketing from January 2007 to December 2010. After Cardiva Medical, Tara went to RTI Surgical and served as the General Manager and Vice President from January 2004 to December 2007.

Tara Zerby has earned an MBA in Business/Commerce from the University of Wisconsin-Milwaukee, a MA in Philosophy from [Georgia State University](/org/georgia-state-university), and a BA in Political Philosophy, Math, and Chemistry from [Wake Forest University](/org/wake-forest-university).

Their manager is Randel Woodgrift, SVP, Cardiac Rhythm Management.

Tara Zerby

Joe Provost has over 25 years of experience in the medical device industry, with a focus on cardiac rhythm management (CRM), electrophysiology (EP), and structural heart. Joe currently serves as Divisional Vice President of US Sales for Electrophysiology at Abbott. Prior to joining Abbott, Joe served as Vice President of Cardiac Sales for CRM, EP, Structural Heart, Cardiology & Heart Failure at St. Jude Medical from 2011 to 2016. From 2001 to 2011, they were Sales Director for Western US Electrophysiology at [Boston Scientific](/org/boston-scientific). Joe Provost received their undergraduate degree from [Northeastern University](/org/northeastern-university).

Joe Provost has a Bachelor's Degree from the [University of New Hampshire](/org/university-of-new-hampshire) and a Master of Arts from Columbia University in the City of New York.

They work with Bryan DaHarb - VP, Commercial Excellence, Heart Failure, Uli Michel - Divisional VP, Electrophysiology & Heart Failure EMEA, and Luxin Wang - Division VP, APAC Electrophysiology & Heart Failure. Joe Provost reports to Michael J. Pederson, SVP, Electrophysiology and Heart Failure.

Joe Provost

Lance Mattoon has been with Abbott since January 2017, where they currently serve as the Vice President of Quality for the Heart Failure division. Prior to this, they were with St. Jude Medical as the Vice President of Development Quality from April 2011 to January 2017. From March 2009 to March 2011, they were with Zimmer as the Associate Director of Corporate Quality Compliance. From August 2007 to December 2008, they were with Nestle Healthcare Nutrition as the Associate Director of Quality Assurance. From October 2005 to August 2007, they were with [Boston Scientific](/org/boston-scientific) as the Corporate Senior Quality Manager for Alliance Quality Management, overseeing due diligence for acquisitions of companies and intellectual property, distribution agreements, and contract manufacturing. From June 2001 to September 2005, they were with Agfa HealthCare as the Head of RAQA. From January 1998 to December 2001, they were with CR Bard as the Quality Manager. From January 1997 to December 1998, they were with Gambro Healthcare as a Quality Engineer.

They work with Uli Michel - Divisional VP, Electrophysiology & Heart Failure EMEA, Bryan DaHarb - VP, Commercial Excellence, Heart Failure, and Luxin Wang - Division VP, APAC Electrophysiology & Heart Failure. Lance Mattoon reports to Michael J. Pederson, SVP, Electrophysiology and Heart Failure.

Lance Mattoon

Denise LaMotte is the Director of Benefits at Abbott. Denise has been with the company since July 2017, and in their current role, they lead strategy development and recommendations for U.S. health and welfare benefits for employees and retirees. This includes overseeing benefit compliance activities, vendor selection, vendor and program management, and benefit implementation and execution.

Prior to joining Abbott, Denise was with Walgreen Co. for over 14 years, where they advanced through multiple positions with increasing responsibility. These roles included Compensation Services Manager, Benefits & Employee Communications Director, Benefits Manager, and Compensation & Benefits Project Manager. During their time at Walgreen Co., Denise was key in developing and implementing company-wide benefit programs for over 240,000 team members. This included designing and implementing the company’s first broad-based vision plan and consumer-directed health plan.

Denise LaMotte has a type AM degree in Labor & Industrial Relations from the [University of Illinois at Urbana-Champaign](/org/university-of-illinois-at-urbana-champaign), as well as a BA in Economics from the same school. Denise is certified by UC Berkeley Executive Education in Leading Innovative Change and by WorldatWork in Certified Benefits Professional (CBP) and Certified Compensation Professional (CCP).

Denise LaMotte reports to Mary K. Moreland, EVP, Human Resources. They work with Nancy Panetta - Global Divisional VP, Human Resources, Kevin Ball - Global Director, Training and Development, and Maureen Clayton - VP and Executive Director, Clara Abbott Foundation.

Denise LaMotte

Kevin Ball is the Global Director of Training and Development at Abbott. Prior to this, Kevin was with Abbott Diagnostics Business as an Account Manager responsible for sales of immuno-assay, chemistry, and hematology products in West Virginia / eastern Kentucky market. Kevin has also been with Century Resources, LLC as Field Sales Manager responsible for sales and marketing of various fund raising and promotional products focused primarily on educational institutions. Kevin has also been a Tennis Professional with Huntington Tennis Club / Sleepy Hollow Country Club. Kevin has a bachelor's degree in Sports Medicine from [Marshall University](/org/marshall-university).

They work with Maureen Clayton - VP and Executive Director, Clara Abbott Foundation, Kathy Ross - VP, U.S. Workplace Solutions, and Denise LaMotte - Director, Benefits, Global Benefits Practice Center. Kevin Ball reports to Mary K. Moreland, EVP, Human Resources.

Kevin Ball

Ann H. Chen is the Senior Counsel of Litigation and Labor & Employment at Abbott. Ann has been with the company since 2015 and in their current role, they support several global business units on all aspects of their labor & employment needs, including counseling, litigation, and transactions. Chen also works closely with senior leaders on developing and implementing diversity & inclusion strategies.

Prior to joining Abbott, Chen was a Counsel at Mars, Incorporated where they led a global team of 5 legal professionals in overseeing the marketing and brand portfolios of the global Chocolate, Food, and Drinks businesses. Her focus was advising on trademark, social media, digital, copyright, design rights, litigation and enforcement, licensing, domain name and related matters.

Chen began their legal career as an Associate at Goldberg Kohn Ltd. from 2006 to 2008 before moving to [Kirkland & Ellis](/org/kirkland-ellis-llp) where they worked as an Associate from 2003 to 2006.

Ann H. Chen received their Juris Doctor from the University of Michigan Law School and their Bachelor of Arts in Political Science from [Yale University](/org/yale-university). Ann also attended the Illinois Mathematics and Science Academy and William Fremd High School.

Ann H. Chen reports to Hubert L. Allen, EVP, General Counsel & Secretary. They are on a team with and Linda Barrios - Senior Counsel, IT and Managed Services.

Ann H. Chen

Linda Barrios is the Senior Counsel for IT and Managed Services at Abbott. Linda has extensive experience in technology contracting, including software licensing, maintenance and support, Cloud, software as a service (SaaS), internet service provider, outsourcing, telecommunications, technology infrastructure, NDA, software/systems integration agreements, equipment purchase/lease agreements and other general commercial contracts.

Prior to joining Abbott, Linda was the Senior Counsel for the Data & Technology Practice Group at McDonald's Corporation from March 2013 to January 2017. In that role, they collaborated with business teams to facilitate the achievement of company objectives by understanding primary commercial requirements and ensuring that transactional terms are consistent with such requirements. Linda also participated in cross-functional project teams charged with deploying technology and digital initiatives, and was responsible for identifying and understanding the potential legal risks associated with each initiative, and engage domestic and international attorneys with subject matter expertise to address such risks. Additionally, Linda managed and supported a variety of SaaS/Cloud transactional and compliance issues, including data privacy, security, open source and brand issues.

Before their time at McDonald's Corporation, Linda served as General Counsel to Restaurant Application Development International, LLC., where they provided counsel on various global legal risks including employment, contract, real estate, branding guidelines, data privacy and other business matters as required. Linda is a positive and collaborative partner with a dedication to clients who is able to work independently to resolve issues appropriately and efficiently.

Linda Barrios has a Juris Doctor from DePaul University College of Law and a B.B.A in Economics from Loyola University.

Some of their coworkers include and Ann H. Chen - Senior Counsel, Litigation and Labor & Employment. Linda Barrios reports to Hubert L. Allen, EVP, General Counsel & Secretary.

Linda Barrios

Brandy Corneil has been in the medical device industry for over 20 years. Brandy started their career at [Boston Scientific](/org/boston-scientific) as a Regulatory Compliance Manager and then moved to [Medtronic](/org/medtronic) where they spent 8 years in various positions including Senior MDR/Vigilance Manager and Sr. Program Manager (Corporate Quality). In May 2013, they joined St. Jude Medical as the Director of Complaints & Infrastructure. After 3 years at St. Jude, they moved to their current role as Sr. Director of International Quality for Abbott.

Brandy Corneil has a BA in Spanish and Portuguese from the [University of Minnesota](/org/university-of-minnesota), a BA in International Relations (Economics & Political Science) from the [University of Minnesota](/org/university-of-minnesota), and is a Certified Quality Auditor from the American Society for Quality.

Some of their coworkers include Allen Pofahl - Division VP, IT, Abbott Medical Devices, Elizabeth Cushman - Division VP and Associate General Counsel, Medical Devices, and Chris Tyberg - Division VP, Information Security Abbott Medical Devices. Brandy Corneil reports to Lisa D. Earnhardt, EVP, Medical Devices.

Brandy Corneil

Ofer Elboher is the current General Manager of Electrophysiology for Abbott in Australia and New Zealand. Prior to this, they served as Business Unit Director for Neuromodulation at St. Jude Medical from June 2012 to January 2017. In this role, they were responsible for developing and implementing the national sales and marketing strategy, as well as an effective sales force, to meet revenue and expense targets within the NMD Division. Ofer was also a member of St Jude ANZ's senior leadership team.

Elboher has extensive experience in developing relationships with key opinion leaders and customers to develop sales and business strategies in line with company strategies. Ofer is also skilled in budgeting, forecasting, operation planning and reporting requirements.

Under their leadership, the team at Abbott has seen great success in meeting their goals and objectives. Elboher is credited with motivating their employees and creating a strong teamwork environment that has resulted in positive outcomes for the company.

Ofer Elboher has an MBA in Corporate Strategy from Imperial College Business School, a Master's Degree in Health Economics from [Deakin University](/org/deakin-university), and a BSc (Hon) in Pharmacy from the [University of Sunderland](/org/university-of-sunderland).

Their manager is John M. Capek, EVP, Ventures. Ofer Elboher works with and Michael J. Pederson - SVP, Electrophysiology and Heart Failure.

Ofer Elboher

Mark Szewczyk is the current General Manager of the Molecular Diagnostics Division at Abbott. Mark has held this position since September 2016. Prior to that, they were the Vice President of Global Commercial Operations for Molecular Diagnostics at Abbott from September 1998 to June 2004. Mark also held the position of Marketing Manager for Contracting at Abbott from June 1993 to September 1998. Before joining Abbott, Mark was the General Manager of The Cleveland Clinic Home Care from June 1993 to September 1998.

Mark Szewczyk has a Bachelor of Science in Pharmacy from [The Ohio State University](/org/the-ohio-state-university) and a Master of Business Administration (MBA) from [Drexel University](/org/drexel-university).

Mark Szewczyk works with Christopher Slachta - Divisional VP, Operations, Molecular Diagnostics, Edita Apuokiene - VP, Molecular Diagnostics, EMEA, and Stuart Knight - VP, Global Accounts, Infectious Disease Rapid Diagnostics. Their manager is Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics.

Mark Szewczyk

Sheri Keith is the treasurer and controller for the Clara Abbott Foundation at Abbott. Sheri previously worked as a senior finance manager for Abbott Laboratories from September 2010 to February 2014.

Sheri Keith has a Bachelor of Science in Accounting from [Illinois State University](/org/illinois-state-university).

Sheri Keith reports to Maureen Clayton, VP and Executive Director, Clara Abbott Foundation.

Sheri Keith

Mahesh Natarajan is currently the GM of Molecular Diagnostics for Asia Pacific at Abbott. Prior to this, they were the Head of Commercial Operations for Singapore and Export Markets at Takeda from January 2010 to January 2015. Before Takeda, they were a Manager at [Accenture](/org/accenture) from October 2004 to January 2010 in Management Consulting. [PepsiCo](/org/pepsico) hired him as a Management Trainee from July 2003 to October 2004.

Mahesh Natarajan has a postgraduate diploma in management from the Indian Institute of Management, Lucknow. Mahesh also has a bachelor's degree in chemical engineering from the [Indian Institute of Technology, Madras](/org/indian-institute-of-technology-madras). Furthermore, they have a high school diploma from P.S. Senior Secondary School, Chennai. Finally, they have a certification from APICS: Association for Operations Management in Certified Supply Chain Professional (CSCP).

Their manager is Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics. They work with Mylene Moraes - Executive Assistant to EVP, Rapid and Molecular Diagnostics, Stuart Knight - VP, Global Accounts, Infectious Disease Rapid Diagnostics, and Edita Apuokiene - VP, Molecular Diagnostics, EMEA.

Mahesh Natarajan

Kathy Ross is the current VP of U.S. Workplace Solutions at Abbott. Prior to this, they served as Senior Vice-President at ADP from January 1994 to February 2020, where they were responsible for sales segments from small businesses to large enterprise businesses. Ross was also the Director of Business Dining at ARAMARK from June 1992 to August 1994, where they were the operations site leader for a Fortune 500 multi-million dollar account, leading food service, catering, vending, and customer relationship management.

Kathy Ross studied at Cornell University, completing a Bachelor of Science in School of Hotel Administration. Kathy later pursued a Master of Business Administration (M.B.A.) at [Northwestern University](/org/northwestern-university)'s Kellogg School of Management, with a focus in Business Administration, Management and Operations. Ross also holds a financial management certificate from Cornell University's eCornell program.

They work with Maureen Clayton - VP and Executive Director, Clara Abbott Foundation, Heather Greenberg - Director, Global Design and Operations Leader, Learning & Development, and Nancy Panetta - Global Divisional VP, Human Resources. Kathy Ross reports to Mary K. Moreland, EVP, Human Resources.

Kathy Ross

Chris Miller is the Divisional VP, Global Brand Strategy & Innovation at Abbott. Chris has over 20 years of experience in the industry, and has held senior positions at FCB Global and Draftfcb. Chris is a thought leader in the industry, and has spoken at Digiday, Cannes, DMA, and the Chief Digital Officer Summit. Chris has also served on the jury for the Cannes Lions, Digiday Mobile Awards, and IAB MIXX Awards. Chris has a proven track record of helping companies grow their digital capabilities and drive growth.

Chris Miller has a BA in Journalism from [Drake University](/org/drake-university). Chris is a triple major in Advertising, Media Graphics, and Radio/Television.

They work with Simon Goldberg - Senior Director, Global Digital Marketing, Conor Cronin - VP, Marketing & Commercial Ops EMEA, Cardiometabolic, and Paul Bould - VP, Global Marketing Insights & Analytics. Chris Miller reports to Melissa Brotz, Chief Marketing and Communications Officer.

Chris Miller

Adam Bishop is the current US VP of Sales for Infectious Disease Rapid Diagnostics at Abbott. Adam has held this position since January 2016. Prior to that, they were the US Vice President of Sales for Abbott Rapid Diagnostics, Infectious Disease from January 2016 to January 2021. Adam has also been the Area Sales Director for the Critical Care Group at Alere Inc. from May 2011 to December 2012, and the Regional Sales Director for the West at Alere Inc. from April 2009 to May 2011. Adam began their career at Alere Inc. as a Biosite Account Executive from September 2005 to April 2009.

Adam Bishop's educational career includes a Bachelor of Applied Science in Clinical Laboratory Science/Medical Technology/Technologist from Texas Tech University Health Sciences Center.

Some of their coworkers include Mark Szewczyk - GM, Molecular Diagnostics Division, Mahesh Natarajan - GM, Molecular Diagnostics, Asia Pacific, and Stephanie McCallum - Ethics and Compliance Officer, Rapid and Molecular Diagnostics. Their manager is Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics.

Adam Bishop

Mike Quinn has been in the medical device industry for over 25 years. Mike started their career as a sales representative for Guidant Corporation. Mike then spent 10 years at Abbott, where they held various positions including Director of US Commercial Operations. In their current role as Area VP of Sales, Structural Heart at Abbott, they are responsible for sales and marketing of Abbott's structural heart products.

Mike Quinn has a Bachelor's degree in Commerce from [Santa Clara University](/org/santa-clara-university) and a Masters in Technology Management & Marketing from [Santa Clara University](/org/santa-clara-university). Mike also has a certification from the [Federal Aviation Administration](/org/federal-aviation-administration) in Private Pilot.

They are on a team with Sven Seyffert - Area Head and GM, Structural Heart, APAC, Payal Agrawal - GM and Country Head, Structural Heart, India & subcontinent, and Santosh Prabhu - Divisional VP, Product Development, Structural Heart. Mike Quinn reports to Michael Dale, SVP, Structural Heart.

Mike Quinn

Santosh Prabhu is currently the Divisional VP of Product Development for Structural Heart at Abbott. Prior to this, they were a Principal R&D Engineer at [Guidant](/org/guidant) Corporation from July 2000 to September 2005. While at [Guidant](/org/guidant), they were key member of the team responsible for developing bare metal and drug-eluting stent platforms. Santosh also developed Finite Element Analysis (FEA) techniques for the structural analysis of metallic stents designed for coronary and peripheral application and biodegradable stents designed for coronary applications. In addition, they used FEA to perform structural analysis on abdominal aortic aneurysm (AAA) stent grafts and devices used for performing anastomosis procedures. Santosh successfully completed all phases of the FEA needed for the Food and Drug Administration (FDA) IDE and CE Mark filing of the stents. Lastly, they developed CFD models for studying distribution of micro/nanoparticles in blood flow and in arterial wall.

Santosh Prabhu has a Master of Business Administration from Santa Clara University Leavey School of Business, a PhD in Mechanical Engineering from the [University of Delaware](/org/university-of-delaware), and an MS in Aerospace Engineering from the University of Alabama. Santosh also has a B.Tech in Aerospace Engineering from Indian Institute of Technology, Bombay, and has completed Stanford Biodesign Executive Education at [Stanford University](/org/stanford).

Santosh Prabhu reports to Michael Dale, SVP, Structural Heart. Some of their coworkers include Sven Seyffert - Area Head and GM, Structural Heart, APAC, Ryan Derrigan - GM, Structural Heart, Northern Europe, and Dan Silver - GM, Structural Heart, Japan.

Santosh Prabhu

Born in India, Vikash Prasad has worked in the country's healthcare and pharmaceutical industries for over two decades. Vikash started their career at [Tata Motors](/org/tata-motors) in 1992, before moving to GlaxoSmithKline Consumer Healthcare in 1996. In 2006, they took on a commercial integration lead role for the Middle East and Africa region.

Prasad left GlaxoSmithKline in 2017 to join [Sanofi](/org/sanofi) as general manager for their consumer healthcare businesses in Vietnam and Cambodia. Vikash remained with the company for just over a year before moving to Abbott in January 2019.

At Abbott, Prasad is responsible for leading the company's nutrition business in India. Vikash has been with Abbott for over two years, and in September 2020 was promoted to managing director and general manager of the India region.

Vikash Prasad has a PGDBM from XLRI Jamshedpur in Marketing & Finance and a B.E from Maulana Azad National Institute of Technology in Mechanical Engineering. Vikash also has an I.S.C from Little Flower School, Jamshedpur.

Vikash Prasad works with Jawed Zia - VP, Established Pharmaceuticals, India, Hakim Bouzamondo - Divisional Vice President, Head of Global Nutrition Research & Development, and Leo Goldshteyn - Divisional VP, Established Pharmaceuticals, Asia Pacific. Vikash Prasad reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products. and Nilesh Vartak - Head of Supply Chain, Abbott Nutrition, India reports to Vikash Prasad.

Vikash Prasad

Stuart Knight is the current Vice President of Global Accounts for the Infectious Disease Rapid Diagnostics division at Abbott. Prior to this role, they served as Head of Global Accounts for the same division from May 2019 to August 2021. Stuart has over 10 years of experience in global health and business development, with a successful track record of new business development and price-to-win strategies.

Stuart began their career in 2011 at [IQVIA](/org/iqvia), where they supported global health and laboratory system strengthening across critical LMIC markets. In this role, they offered innovations to overcome complex healthcare challenges affecting some of the world’s most vulnerable and underserved patient populations. In 2019, Stuart joined Abbott as Head of Global Accounts for the Rapid Diagnostic division. In this role, they were responsible for new business development and price-to-win strategies for the division.

Stuart’s experience in global health and business development has enabled him to successfully grow the Infectious Disease Rapid Diagnostics division at Abbott. Stuart's knowledge and expertise have been instrumental in providing patients across low and middle income countries with equitable access to affordable and high quality health services.

Stuart Knight studied at [Auburn University](/org/auburn-university) and ICA.

Stuart Knight reports to Andrea F. Wainer, EVP, Rapid and Molecular Diagnostics. They are on a team with Edita Apuokiene - VP, Molecular Diagnostics, EMEA, Adam Bishop - US VP of Sales, Infectious Disease Rapid Diagnostics, and Mylene Moraes - Executive Assistant to EVP, Rapid and Molecular Diagnostics.

Stuart Knight

Caitriona Dunne is the current IQA & Analytical Lab Manager at Abbott. Caitriona has previous experience as a Quality Assurance Manager at O'Brien Fine Foods from October 2016 to November 2020. In their previous role, they were responsible for the management and implementation of the food safety and quality management system, as well as overseeing all aspects of quality assurance and control. Caitriona is also experienced in labour and yield management, annual budgeting, and mock product recalls.

Caitriona Dunne has a Train the Trainer Programme from Invisio, a Lean Sigma Green Belt from LBS Partners, an SCQF Level 5 in ITC Award in Health & Safety in the Workplace from SCQF, a Level 6 in Advanced HACCP Design and Validation based on Risk Assesment from SQT Training Ltd, a Diploma in Professional Competence from Technological University Dublin, and a BSc (Hons) in Undenominated Science from University of Galway.

Their manager is Lorraine Carroll, PQA Site Director. They are on a team with Cormac Rudden - CAPA / Validation Manager, Kathleen Bredican - Compliance Manager, and Natalia Banasik - Micro Lab Manager.

Caitriona Dunne

Claire Lynch is currently a Lead QA Validation Engineer at Abbott. Claire has been in this role since June 2010. Prior to that, they were a QA Validation Engineer at [Kerry Group](/org/kerry-group-plc) from September 2009 to January 2010. Claire has a Bachelor's degree in Science from the University of Limerick.

Claire Lynch completed a certificate in training and development from the Technological University Dublin. Claire then went on to study pharmaceutical science at the Technological University Dublin, where they specialized in chemistry.

They work with Martin Farrelly - QA Validation Engineer, Hannah Byrne - Quality Excellence and PoP Site Lead, and Sarah McDermott - CAPA Specialist. Their manager is Cormac Rudden, CAPA / Validation Manager. and Oonagh McGowan - QC Lab Projects Manager reports to Claire Lynch.

Claire Lynch

Oonagh McGowan is the QC Lab Projects Manager at Abbott. Oonagh has previously worked as a Supply Chain Planner, REACH Supply Chain Co-Ordinator, and Change Control Specialist / SAP Administrator at Abbott Diagnostics.

Oonagh McGowan has a Bachelor of environmental science from the Institute of Technology in Sligo and a Bachelor of civil and water engineering from the Institute of Technology in Sligo. Oonagh also has certification from Sligo Institute of Technology in Introduction to Lean Sigma Quality and City and Guilds in AutoCAD 2D.

Shane McConville - QC Lab Projects Technician, Emer Donohoe - QC Lab Projects Technician report to Oonagh McGowan. Oonagh McGowan reports to Claire Lynch, Lead QA Validation Engineer.

Oonagh McGowan

Ciara Flanagan has over 5 years of experience working as a microbiologist in the food industry. Ciara currently works as a food safety specialist at Abbott, a global healthcare company. Prior to joining Abbott, Ciara worked for The Authentic Food Co., a food manufacturing company, where they were responsible for testing food products for bacteria and other microorganisms. Ciara has also worked for Microlabs Ltd and Food Analytical Services, where they gained valuable experience in the food safety field. Ciara is passionate about helping companies ensure the safety of their food products and preventing foodborne illnesses.

Ciara Flanagan has a Bachelor of Science in Microbiology from University College Dublin and certification in Supervisory Management from Louth Meath ETB. Ciara is currently studying for a degree in eBioPharmaChem at the Dublin Institute of Technology.

Ciara Flanagan reports to Joe Rice, Food Safety Manager.

Ciara Flanagan

Brendon Goodrich has been working in the food and beverage industry for over 25 years. Brendon started their career as a Catering Manager with [Transport for London](/org/transport-for-london) in 1985 and then moved to the BBC in 1990 where they became the Finance & Administration Manager for Catering Services. In 1995, Brendon left the BBC to become General Manager of the Derragarra Inn.

In 1997, Brendon started their own food safety and management consultancy, Goodrich Training & Consultancy. For over 20 years, they have been helping companies with food safety compliance, ISO 22000 auditing, catering tenders and foodservice management. Brendon is also a licensed trainer with EHOA, National Hygiene Partnership and RSPH.

In 2019, Brendon joined Abbott as a Senior QA Compliance Specialist. In this role, they are responsible for ensuring that all Abbott products meet quality standards.

Brendon Goodrich's educational career includes receiving an MBA from [The Open University](/org/cloudworks), an MHCIMA in Hospitality Management from Westminster College, Hotel School, and a B. Sc. in Environmental Science from Westfield College, University of London. Brendon also holds certifications from Abbott in Lean Six Sigma Yellow Belt Certification and from SOLAS in Safe Pass.

Brendon Goodrich reports to Kathleen Bredican, Compliance Manager.

Brendon Goodrich

Shane McConville was a QA Compliance Intern at Abbott from June 2019 to September 2020. Shane is currently a QC Lab Projects Technician at the company.

Shane McConville's educational career began with a Bachelor of Science in Human Nutrition from [Ulster University](/org/ulster-university). Shane then went on to complete a health services/allied health/health sciences, general program at the same school.

Some of their coworkers include and Emer Donohoe - QC Lab Projects Technician. Shane McConville reports to Oonagh McGowan, QC Lab Projects Manager.

Shane McConville

As the Chief Executive Officer of Feeding America, Ms. Babineaux-Fontenot provides Abbott’s Board with substantial experience in organizational governance, strategic planning, and supply chain and infrastructure management, and through her prior financial leadership roles at Walmart, Ms. Babineaux-Fontenot contributes extensive expertise and knowledge of global risk management and corporate finance and accounting matters for a multinational public company.

Claire Babineaux-Fontenot

Fernando Mateus is currently the SVP of International Nutrition at Abbott. 

Prior to joining Abbott in May of 2018, Fernando Mateus served as the CEO of Exeltis USA from July 2016 to April 2018. Prior to that, they were the Region Head for MENA at [Sandoz](/org/sandoz) from June 2010 to May 2016, and before that they were the General Manager at [Sandoz](/org/sandoz) Portugal from January 2006 to July 2010. 

Fernando Mateus began their career in 2005 as the International Product Manager at Mepha. 

Fernando Mateus has over 15 years of experience in the pharmaceutical and healthcare industry. Fernando is an expert in product launches, go-to-market strategies, and commercialization.

Fernando Mateus reports to Robert B. Ford, President & CEO. They are on a team with Melissa Brotz - Chief Marketing and Communications Officer, Jared L. Watkin - SVP, Diabetes Care, and Hubert L. Allen - EVP, General Counsel & Secretary.

Fernando Mateus

Chris Tyberg has over 20 years of experience in Information Technology and Security. Chris is currently the Division Vice President for Information Security at Abbott Medical Devices. Chris has also held the position of Vice President IT and Chief Information Security Officer at St. Jude Medical from September 2005 to October 2018. Prior to that, they worked at Ernst & Young as a Manager from August 1998 to September 2005. Chris has a wealth of experience and knowledge in the IT and security industry and is an asset to any company.

Chris Tyberg completed their undergraduate degree at the University of Minnesota Duluth.

Some of their coworkers include Allen Pofahl - Division VP, IT, Abbott Medical Devices, Brandy Corneil - Sr. Director, International Quality, Medical Devices, and Elizabeth Cushman - Division VP and Associate General Counsel, Medical Devices. Chris Tyberg reports to Lisa D. Earnhardt, EVP, Medical Devices.

Chris Tyberg

Nilesh Vartak is currently the Head of Supply Chain for Abbott Nutrition in India. Nilesh has been with the company since August 2014, and in their current role, they are responsible for a team of eight managers. Nilesh's previous role with Abbott Nutrition was as Director of Business Supply Chain, where they were a member of the Senior Leadership Team and reported directly to the General Manager and Country Head for Nutrition.

In their previous role, Nilesh was responsible for managing the affiliate S&OP process and maintaining forecast accuracy levels below 15%. Nilesh was also responsible for managing a freight and distribution spend of $7.5 million for the India affiliate. Nilesh introduced freight negotiations via a live reverse auction, which led to a 8% reduction in freight costs in 2015. In addition, they were responsible for margin and profitability initiatives that contributed to $460,000 in savings in 2018 and $470,000 in 2019. From 2014 to 2016, Nilesh managed indirect sourcing spends of $10 million for the India affiliate, encompassing agency contracting, commercial print, hotels, events, promotional and gift items.

Nilesh Vartak has a Master of Management Studies (MMS) in Finance from [Jamnalal Bajaj Institute of Management Studies](/org/jamnalal-bajaj-institute-of-management-studies) (JBIMS) and a Bachelor of Engineering (B.E.) in Marine Engineering from Marine Engineering And Research Institute.

Nilesh Vartak reports to Vikash Prasad, Managing Director & GM, Abbott Nutrition, India Region.

Nilesh Vartak

Luxin Wang is the Division VP, APAC Electrophysiology & Heart Failure at Abbott. Luxin has also served on the Board for The [Alcon](/org/alcon) Foundation and as Head APAC Surgical at [Alcon](/org/alcon). Wang began their career in 2004 as the General Manager for Biomet in China.

Luxin Wang has a MBA in Business Administration from [Purdue University](/org/purdue-university), a MS in Computational Engineering from [Mississippi State University](/org/mississippi-state-university), and a bachelor's degree in Chemical Engineering/Machinery from Beijing University of Chemical Technology.

Their manager is Michael J. Pederson, SVP, Electrophysiology and Heart Failure. Some of their coworkers include Uli Michel - Divisional VP, Electrophysiology & Heart Failure EMEA, Bryan DaHarb - VP, Commercial Excellence, Heart Failure, and Lance Mattoon - VP, Quality, Heart Failure.

Luxin Wang

Nancy Panetta is the current Global Divisional VP of Human Resources at Abbott. Nancy has over 25 years of experience in Human Resources, and has held positions at Thomas J. Paul, Inc. and [Ortho Clinical Diagnostics](/org/ortho-clinical-diagnostics).

At Thomas J. Paul, Inc., Nancy served as a Consultant/Human Resources Advisor to the Executive Team. In this role, they were responsible for defining and implementing a comprehensive talent strategy to optimize the performance of the 90-employee, family-owned business. This included building an inaugural HR infrastructure to advance the growth plan, developing new organizational structure and capabilities required to execute current and future business needs, assessing current capabilities against new structure, and identifying gaps and defining recruitment requirements.

At [Ortho Clinical Diagnostics](/org/ortho-clinical-diagnostics), Nancy served as Worldwide Vice President of Human Resources - Office of Chief Operating Officer. In this role, they were a senior business leader partnering with the Chief Operating Officer as [Ortho Clinical Diagnostics](/org/ortho-clinical-diagnostics) transitioned from a business within [Johnson & Johnson](/org/johnson-johnson) to an independent, standalone company. Nancy was accountable for leading human capital pre-IPO strategies and complex change initiatives, building lean, agile organizational structures to enable Ortho's standalone operating model, and building organizational capabilities across multiple global functions. Some of their key accomplishments include:

• Hands-on leadership building scalable infrastructure, processes, and systems supporting Ortho’s new stand-alone operating model and 2020 growth strategy. 
• Led human capital decisions for multiple company-wide improvement initiatives resulting in $107M savings.
• Leveraged partnerships and applied innovative solutions to deliver aggressive IT capability build and realignment of R&D staffing mix; accelerated ROI by delivering ahead of plan and below forecasted costs.
• Cultivated a culture of high performance and employee engagement, resulting in year-over-year improvements against key engagement indices.
• Improved bench strength and achieved strong pipeline depth for all critical positions (80% improvement) in <24 months. 
• Designed, revitalized and led a lean, customer-focused global Human Resources team supporting over 40% of global employee population; team recognized as trusted, credible, delivering exceptional results across multiple functional areas and diverse demographics.

Nancy Panetta has a BSBA in Business Information Systems from Shippensburg University of Pennsylvania and certification from the HR Certification Institute - HRCI in SPHR.

Nancy Panetta works with Heather Greenberg - Director, Global Design and Operations Leader, Learning & Development, Kathy Ross - VP, U.S. Workplace Solutions, and Kevin Ball - Global Director, Training and Development. Nancy Panetta reports to Mary K. Moreland, EVP, Human Resources.

Nancy Panetta

Scott Harper is currently the Division VP of Research and Development at Abbott Diabetes Care. Prior to this, they were the R&D Manager at Abbott Diabetes Care from January 2004 to July 2013. Before their time at Abbott, they worked as an R&D Engineer at Cygnus from January 1999 to December 2003.

Scott Harper attended [UC San Diego](/org/uc-san-diego), where they earned a Bachelor's Degree in Bioengineering.

Scott Harper works with Duncan Williams - Divisonal VP, New Analyte Ventures, Abbott Diabetes Care, Marc Taub - Divisional VP, Technical Operations, Abbott Diabetes Care, and Michael Johnson - Divisional VP Human Resources, Abbott Diabetes Care. Scott Harper reports to Jared L. Watkin, SVP, Diabetes Care.

Scott Harper

Heather Greenberg is the Director of Global Design and Operations Leader for Learning & Development at Abbott. Heather has over thirteen years of experience in the field of education and instructional design. Prior to joining Abbott, Heather was the Director of Learning & Development at PwC, where they led a team of 57 nationwide staff members responsible for designing and developing live learning solutions. Heather has a proven track record in designing and implementing high quality, cutting-edge learning solutions that meet stakeholder’s strategic priorities. Heather is an expert in instructional design, adult learning theory, innovative educational technologies, and problem-based learning approaches. Heather is also a skilled project manager, with experience in leading large-scale conferences and classroom and technology-enabled learning programs.

Heather Greenberg has a Bachelor of Science in Human Ecology from [The Ohio State University](/org/the-ohio-state-university). Heather is certified by the University of California, Berkeley in Accelerating Change Readiness & Agility, Langevin Learning Services in Certified Instructional Designer/Developer, and [Project Management Institute](/org/project-management-institute) (PMI) in Project Management Professional (PMP).

They are on a team with Denise LaMotte - Director, Benefits, Global Benefits Practice Center, Maureen Clayton - VP and Executive Director, Clara Abbott Foundation, and Nancy Panetta - Global Divisional VP, Human Resources. Heather Greenberg reports to Mary K. Moreland, EVP, Human Resources.

Heather Greenberg

Elizabeth Cushman is the Division VP and Associate General Counsel for Medical Devices at Abbott. Elizabeth has been with the company since 1997 and in their current role since 2001. Prior to joining Abbott, Ms. Cushman was an associate with Thelen Reid & Priest from 1997 to 2001 and Keesal, Young & Logan from 1995 to 1997.

Elizabeth Cushman attended the University of California, Berkeley, where they earned a Bachelor of Arts (BA). Elizabeth then attended the University of the Pacific - McGeorge School of Law, where they earned a Juris Doctor.

Their manager is Lisa D. Earnhardt, EVP, Medical Devices. They are on a team with Allen Pofahl - Division VP, IT, Abbott Medical Devices, Chris Tyberg - Division VP, Information Security Abbott Medical Devices, and Brandy Corneil - Sr. Director, International Quality, Medical Devices.

Elizabeth Cushman

Uli Michel is the current Divisional VP, Electrophysiology & Heart Failure EMEA at Abbott. Uli has over 25 years of experience in the medical device industry. Uli started their career at [Guidant](/org/guidant)/CPI in 1989 in sales and clinical research. Uli then became the Director of Clinical Research at [Guidant](/org/guidant) in 2000. In 2007, they joined [Boston Scientific](/org/boston-scientific) as VP & General Manager Germany Group. In 2013, they started their own company, Michel Healthcare Consulting.

Uli Michel has a degree in Biomedical Engineering from [Technische Hochschule Mittelhessen](/org/technische-hochschule-mittelhessen) and a certification from Columbia University - Columbia Business School in Leading Strategic Growth: Executive Education Program with Columbia Business School and Execonline, Inc.

Their manager is Michael J. Pederson, SVP, Electrophysiology and Heart Failure. Uli Michel works with Bryan DaHarb - VP, Commercial Excellence, Heart Failure, Luxin Wang - Division VP, APAC Electrophysiology & Heart Failure, and Joe Provost - Divisional VP, US Sales, Electrophysiology.

Uli Michel

Ryan Derrigan is currently the GM of Structural Heart for Northern Europe at Abbott. Prior to this, they were the Marketing and Therapy Sales Director at [Medtronic](/org/medtronic) from January 2007 to December 2008. From January 2002 to December 2007, they were the Marketing Manager for EMEA at [Johnson & Johnson](/org/johnson-johnson). Ryan also spent time as the Head of Marketing for UK at ST JUDE MEDICAL from January 2008 to December 2013. Finally, they were a Summer Associate on the CEO's Strategic Advisory Staff at SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (SAIC) from June 2001 to August 2001.

Ryan Derrigan graduated from The Wharton School with an MBA in finance, marketing, and strategy.

Ryan Derrigan reports to Michael Dale, SVP, Structural Heart. Some of their coworkers include Hugues Gervais - Divisional VP, Structural Heart, EMEA, Payal Agrawal - GM and Country Head, Structural Heart, India & subcontinent, and Sven Seyffert - Area Head and GM, Structural Heart, APAC.

Ryan Derrigan

Scott House is Abbott’s Senior Vice President, Quality Assurance, Regulatory and Engineering Services. He was appointed to this position in March 2020.

Scott joined Abbott in 1990 as a member of the Abbott Engineering Professional Development Program, and rose through a variety of management roles in both quality and operations, including Divisional Vice President, Operations for Abbott’s Diabetes Care business. Prior to assuming his current responsibilities, Scott served as Senior Vice President, Quality Operations.

In his current role, Scott leads a global organization dedicated to ensuring that Abbott’s quality, regulatory and engineering values are consistently applied across the corporation, helping ensure the highest quality products for our customers, strict compliance with global regulatory requirements, and a safe environment Abbott colleagues around the world.

J. Scott House

Michael Dale is Senior Vice President of the Structural Heart division at Abbott. In this role, he leads the vision and strategy for the business, which is dedicated to the design and provision of device and management solutions for the treatment of structural heart disease.

As an accomplished medical device executive, Mr. Dale has over 30 years of experience leading transformative, high-technology medical device companies in the cardiovascular, neuromodulation, diabetes, and electrophysiology markets. His past executive leadership roles span both public and private medical device companies, including [GI Dynamics](/org/gi-dynamics), Helical Solutions, ATS Medical, Endocardial Solutions, Cyberonics, St. Jude Medical, and Edwards Life Sciences. 

Mr. Dale has been an active director and served on the boards of [Preceptis Medical](/org/hummingbird-ear-tubes), Enpath Medical, Rhythmia Medical, [NeoChord](/org/neochord), the Advanced Medical Technology Association (AdvaMed), and St. Mary’s University Council of Regents for the School of Graduate and Professional Programs. At present, he serves on the advisory board of [Purdue University](/org/purdue-university)’s Weldon School of Biomedical Engineering and California Polytechnic State University’s Center for Innovation & Entrepreneurship as Student Mentor.

Mr. Dale holds a Bachelor of Science degree from California Polytechnic State University in San Luis Obispo, California.

Michael Dale

As Abbott’s Executive Vice President, Human Resources, Mary Moreland leads the company’s efforts to support and develop employees, to help them both support Abbott’s mission and live their own best possible lives.

Prior to assuming her current role in August 2019, Mary served as Abbott’s Divisional Vice President, Compensation and Benefits.

Mary has dedicated her entire career to the world of benefit and compensation programs. She joined Abbott in 2011, as Divisional Vice President, Global Retirement Programs and HR M&A, after working as a benefits consultant in healthcare, hospitals and manufacturing.

Reflecting on her experience to date, Mary says, “My greatest satisfaction has come from seeing people I have managed or mentored grow and develop and be recognized for their achievements.”

In addition to leading Abbott’s Human Resources organization, Mary also serves as the President of the Clara Abbott Foundation.

She earned her bachelor’s degree in Applied Math and Economics from [Harvard University](/org/harvard), Cambridge, Massachusetts.

Mary K. Moreland

Cormac Rudden

stephanie shipman

Cathy Faoa-Danielson

Teresa La Parra Albaladejo

Eric Ziemer

Kimberley Krapek

Andrea Wainer is Abbott’s Executive Vice President, Rapid and Molecular Diagnostics. She was appointed to this role in June 2019.

Andrea joined Abbott in 1997 and served in a variety of roles within our pharmaceuticals business, including divisional vice president and general manager, renal care. She then led our Animal Health business, which was acquired by [Zoetis](/org/zoetis) in February 2015. Immediately prior to assuming her current responsibilities, Andrea served as Vice President, Molecular Diagnostics.  

In her current role, Andrea leads two innovative businesses; one a leader in molecular diagnostics and the analysis of DNA and RNA at the molecular level; the other the world’s leading provider of rapid point-of-care diagnostics. Each of these offers products that provide clinicians with actionable information that can contribute to better clinical, operational and economic outcomes.

Andrea earned her bachelor’s degree in accounting from the John M. Olin School of Business, Washington University, St. Louis, Missouri, and her Masters in Business Administration from the Kellogg School of Management, [Northwestern University](/org/northwestern-university) in Evanston, Illinois.

Andrea F. Wainer

John Ginascol is Abbott's Executive Vice President, [Core Diagnostics](/org/corediagnostics). He was appointed to this role in June 2019. Previously, John served as Vice President, Supply Chain for the company's Nutrition business.

In his close to 40-year career in health care, John has amassed a breadth of experience that covers pharmaceuticals, hospital products, medical devices, and nutrition products. In his current role, John is leading a business that is transforming how diagnostic results are delivered – and ultimately how they affect patient care.

Outside of Abbott, John serves on the Board of Directors of the Lake Forest Graduate School of Management, and on the Chicago’s historical Washington Square Park Advisory Committee.

John earned a bachelor of science degree in Chemistry from the University of Texas, Austin, and a Master's in Business (M.B.A.) from the Lake Forest Graduate School of Management.

John F. Ginascol

In his role as Senior Vice President, Emerging Markets in Abbott's branded medicines business, Sammy ensures access to Abbott’s medicines and brands in the world's fastest-growing regions.

Prior to assuming this position in February 2019, Sammy served as Divisional Vice President, Global Marketing and Commercial Execution.

He joined Abbott in 2014, having previously served as Vice President Europe for Omega Pharma (now [Perrigo](/org/perrigo)).

In his Abbott career, Sammy has built on our company's longstanding focus on commercial execution, strengthening his marketing team, building our portfolio of sustainable brands, and driving above-market growth in his areas of responsibility.

Sammy earned his Master of Business Administration degree, with an emphasis in Marketing and International Business, from the University of Texas at Arlington and his Bachelor of Science in Accounting from Minnesota State University. He has also followed executive education programs with Harvard, Stanford, and Northwestern Business schools.

Sammy G. Karam

Mike Pederson is Abbott's Senior Vice President, Electrophysiology and Heart Failure. He was appointed to this role in April 2020.

Mike joined Abbott in 2015, as Divisional Vice President, Abbott Electrophysiology, to help Abbott build a cardiac arrhythmia business through a combination of strategic acquisitions and organic growth.  

Prior to that, he served as Chief Executive Officer of VytronUS, Inc.

Mike takes real pride in the life-changing technologies that Abbott offers. "Our work allows patients to live longer and better," he says. "Patients that get our devices go from not being able to climb stairs or do other daily activities to living active lives."

Mike received his bachelor of science degree in Electrical Engineering from the University of Wisconsin - Madison; and his Masters in Business Administration from the University of Chicago.

Michael J. Pederson

Jared Watkin is Abbott’s Senior Vice President, Diabetes Care.

Prior to assuming this role in June 2015, he served as Divisional Vice President, Technical Operations.

Jared joined the company in 1996, when Abbott acquired Medisense, Inc. Since then, he’s held a number of key positions in Abbott Diabetes Care, including Senior R&D Director and Divisional Vice President, Research and Development.

In what he describes as his "proudest Abbott moment," Jared led the team that developed the innovative Freestyle Libre Flash Glucose Monitoring System; and as he looks to the future, he's committed to "keeping Abbott Diabetes Care at the forefront of innovation, allowing us to provide better health, and a fuller life, to people with diabetes."

Jared earned his Bachelor of Science degree in Biochemistry from the University College of Wales, Aberystwyth, United Kingdom.

Jared L. Watkin

As Abbott's Senior Vice President, International Nutrition, Joe Manning is responsible for commercial operations in Southeast Asia, Europe/Middle East/Africa and Latin America. He was appointed to this role in January 2017.

Since joining Abbott in Canada as a sales representative in 1995, Joe has held a variety of roles within Abbott’s Pharmaceutical and Nutrition organizations. Prior to his current appointment, Joe served within Abbott Nutrition as Commercial Director for Europe/Canada, as General Manager starting our commercial operations in Russia/CIS countries, as General Manager in Indonesia and, immediately prior to assuming his current role, as Vice President, Nutrition, Asia Pacific.

While in Russia, Joe served as an advisor to Deti Nashe, initiating programs whose goal is to enroll and educate caregivers in orphanages on how to decrease social disorders related to children’s prolonged institutionalization.

Joe received his bachelor’s degree in accounting from St. Mary’s University in Halifax, Nova Scotia, Canada.

Joseph Manning

John Capek, Ph.D., is Executive Vice President, Ventures. Dr. Capek was appointed to his current position in June 2015. In this role, he leads Abbott’s venture investment organization as well as new ventures, including Abbott Electrophysiology. Previously, he had served as Executive Vice President, Medical Devices, and Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business.

Before joining Abbott, Dr. Capek served in various management roles at Guidant Corporation, including president, Guidant Vascular Intervention and vice president and general manager of Bioabsorbable Vascular Solutions. He also served as vice president and general manager of Guidant Germany and vice president, marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company.

He has a bachelor's degree in biomedical engineering, a master's degree in biomedical engineering, a master's degree in electrical engineering, a Ph.D. in biomedical engineering and a master's degree in business administration from [Rensselaer Polytechnic Institute](/org/rensselaer-polytechnic-institute).

John M. Capek

Chris Calamari is Abbott's Senior Vice President, U.S. Nutrition. He was appointed to this role in July 2021. Prior to assuming this role, Chris served as Vice President, Pediatric Nutrition.

Chris joined Abbott in 2005 and has held marketing positions in the company's Nutrition and Pharmaceuticals businesses. Earlier in his career, he was General Manager in Abbott's Pharmaceuticals Products Division, where he led strategy and commercial operations for the Virology franchise.

Prior to working at Abbott, Chris served in a variety of progressively responsible marketing roles at Unilever.

He earned his MBA with an emphasis in marketing from the Stephen M. Ross School of Business at the University of Michigan. His bachelor’s degree was earned at [Yale University](/org/yale-university).

Christopher J. Calamari

Lou Morrone is Abbott's Senior Vice President, Rapid Diagnostics. He was appointed to this role in July 2021. Prior to assuming his current role, he served as Vice President, Transfusion Medicine.

Since joining Abbott in 2004, Lou has held several leadership positions within Diagnostics.

Lou earned his bachelor's degree in chemical engineering and economics from the University of Wisconsin-Madison, and his master's degree in business administration from the University of Chicago.

Louis H. Morrone

Julie is Abbott's Senior Vice President, Vascular. She was appointed to this role in July 2021. Prior to assuming this role, Julie served as Divisional Vice President, U.S. Commercial in Abbott's Diabetes Care business.

Julie joined Abbott in 1995 as a pharmaceutical sales rep and has risen through a series of positions of increasing responsibility across multiple Abbott businesses, including more than 10 years in Abbott Vascular prior to joining Diabetes Care.

Before joining Abbott, she worked in business television production and media consulting.

Julie holds a bachelor's degree in communications from Jackson State University in Mississippi and a master's degree in broadcast management from [Southern Methodist University](/org/southern-methodist-university) in Dallas, Texas.

Julie Tyler

Gabriel Ochoa

Paula Andrea Cotes

As Vice President and Treasurer of [The Clorox Company](/org/the-clorox-company), Ms. Gonzalez is responsible for treasury, investor relations and real estate matters, and through her prior financial roles in several of its businesses, has considerable experience providing financial leadership to a multinational public company with multiple businesses, contributing significant financial expertise and knowledge of financial statements, corporate finance and accounting matters.

Paola Gonzalez

General McDew is a retired four-star general who served for 36 years in the United States military before retiring in October 2018. From August 2015 to August 2018, General McDew served as Commander, U.S. Transportation Command, the single manager for global air, land and sea transportation and patient movement for the [U.S. Department of Defense](/org/united-states-department-of-defense). Previously, he also served as Vice Director for Strategic Plans and Policy for the Joint Chiefs of Staff, Military Aide to the President, Director of Air Force Public Affairs, and Chief of Air Force Senate Liaison Division.

Through his extensive leadership in the [U.S. Air Force](/org/u-s-air-force), General McDew contributes significant experience managing large, complex global operations, including strategic planning, security and risk management, and supply chain and infrastructure management.

Darren W. McDew

Robert Ford is Abbott's President and Chief Executive Officer.

Previously, he served as President and Chief Operating Officer, with responsibility for all of the company's operating businesses; and Executive Vice President, Medical Devices, leading our Diabetes Care, Cardiovascular and Neuromodulation businesses.

He joined Abbott's Diagnostics division in 1996 as a Business Unit Manager in Diabetes Care. He subsequently held various positions of increasing responsibility for Abbott's Diagnostics, Nutrition and Diabetes Care businesses.

Mr. Ford earned a bachelor's degree from [Boston College](/org/boston-college) and a master's degree in business administration from [UC Berkeley](/org/uc-berkeley), Haas School of Business.

Robert B. Ford

Robert Funck is Abbott’s Executive Vice President, Finance and Chief Financial Officer. He was appointed to this role in March 2020. He previously served as Senior Vice President, Finance and Controller.

He joined Abbott in 1987 and has since held a number of financial management positions including Vice President, Controller; Vice President, Internal Audit; Vice President, Treasurer; and Divisional Vice President and Controller in Abbott’s pharmaceutical business.

Prior to joining Abbott, Bob worked as part of the audit group for [KPMG](/org/kpmg) and was a Certified Public Accountant.

Robert Funck

Adrienne Foster

Marc Lam is the Divisional VP & Controller, Established Pharmaceuticals at Abbott. Marc was previously with Solvay Pharmaceuticals from January 2005 to December 2010, where they were the Sr. VP Finance Manufacturing & Supply and CFO Abbott Products Operations AG.

After completing their undergraduate degree, Marc Lam worked in executive development at IMD.

Some of their coworkers include Jim Jin - GM, Established Pharmaceuticals, China, Alejandro Wellisch - SVP, Established Pharmaceuticals, Latin America, and Sammy G. Karam - SVP, Emerging Markets Established Pharmaceuticals. Marc Lam reports to Daniel Salvadori, EVP & Group President, Established Pharmaceuticals & Nutritional Products.

Marc Lam

Alejandro Wellisch is Abbott's Senior Vice President, Established Pharmaceuticals, Latin America. He assumed this role in October 2017.

Alejandro previously served as General Manager for Abbott's pharmaceutical business in Argentina, Bolivia, Paraguay and Uruguay.  Prior to joining Abbott, he worked for [Pfizer](/org/pfizer), [Novartis](/org/novartis) and CFR Pharmaceuticals across the U.S. and in Latin America.

Under Alejandro's leadership, Abbott's pharmaceutical business in Latin America continues to bring high-quality, trusted and affordable medicines tailored to local markets. "As an Argentinian, I'm fulfilling a life-long dream to help people in Latin America achieve new heights through better health."

Alejandro earned his bachelor's degree in management from the University of San Andrés in Buenos Aires.  He later earned an MBA from [Cornell University](/org/cornell-university) in New York.

Alejandro Wellisch

Daniel Salvadori is Abbott's Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products. He was appointed to this role in December 2021.

Previously, Daniel served as Abbott's Executive Vice President, Nutritional Products, and as Senior Vice President, Established Pharmaceuticals, Latin America.

Prior to joining Abbott, Daniel was Chief Executive Officer, LATAM for CFR Pharmaceuticals.

Daniel earned his master's degree in business administration from the [Harvard Business School](/org/harvard-business-school), Boston, Massachusetts.  He is fluent in English, Spanish, French and Italian.

Abbott

Org chart

Teams

Leadership Team

CEO and Executive Team

AN Cootehill QA Department

Board of Directors

Founding Team

Behind the scenes

Discover similar companies